Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system.
about
Molecular classification and prediction in gastric cancerRecent advances in proximal gastric carcinoma.Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer.Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancerCMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancerNegative node count improvement prognostic prediction of the seventh edition of the TNM classification for gastric cancer.Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems.Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancerEfficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study.Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression.Correlation between expression of NF-E2-related factor 2 and progression of gastric cancer.The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage IIIComparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.A comparison of patient characteristics, prognosis, treatment modalities, and survival according to age group in gastric cancer patients.Her2/neu testing in gastric cancer: evaluating the risk of sampling errorsCombined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancerMembers of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosisValidation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter studyMuscle RAS oncogene homolog (MRAS) recurrent mutation in Borrmann type IV gastric cancer.Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative ResectionClinical significance of lymph node metastasis in gastric cancer.Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network.Sequential endoscopic ultrasound identifies predictive variables for relapse-free follow-up after neoadjuvant chemotherapy in gastric cancer.What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer.Snail is an independent prognostic predictor for progression and patient survival of gastric cancer.Validation of the American Joint Commission on Cancer (8th edition) changes for patients with stage III gastric cancer: survival analysis of a large series from a Specialized Eastern Center.Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.Optimal submucosal invasion of early gastric cancer for endoscopic resection.Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea.Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?Evaluation of the staging systems for gastric cancer.IL-32 expression is an independent prognostic marker for gastric cancer.Comparison of the 7th and 8th editions of the American joint committee on cancer TNM classification for patients with stage III gastric cancer.The lymph node ratio as a prognostic factor for gastric cancer.A comprehensive analysis comparing the eighth AJCC gastric cancer pathological classification to the seventh, sixth, and fifth editions.
P2860
Q26783806-6D614C79-4ED9-41C8-A7CC-2FC4E543163DQ30251478-6238B58B-DB37-42BA-B84A-EEDFC471F749Q31060222-D893CAF4-62BC-4A72-8C0B-0A39EA4BD9C5Q33926592-72E747E8-67BE-43B9-9742-001D18628054Q34996337-32CCC720-33FD-404E-B87F-E2671CE9B5D2Q35051708-3D52A8A1-C37D-4D20-B467-BE031A125D7AQ35069303-2AD640D2-ED2D-4A9E-933C-FF0EADB95EE1Q35856796-714E9E4A-4A40-49C9-BE9D-F1659C2E13D6Q35953753-51E16828-4A54-4695-850D-7153B21CD46AQ36065429-42CBD931-BEBA-4AFD-A9C0-635BEB78F82FQ36078921-6BB3A5C5-AAF5-41D4-89ED-950B7C589A4EQ36111572-7560D659-DFF4-4CF6-B005-1D6098003433Q36182990-D0F43126-6ACA-453E-BEA0-BC8A23B0928BQ36328759-D3C5B63C-1212-4ADB-B5AE-B534F435C577Q36336072-6D4077F3-CB56-4904-96FE-A9139AB4093EQ36524077-1D7E9C33-591C-4B3E-AE4A-2E1C0D3203ABQ36615782-2E77AA87-02AD-4165-AFE2-109CAFB6614EQ36952625-C68715CB-345C-44E5-989E-CE7DABBF2BD5Q37235507-6477E723-0D0C-4DB7-A019-CF14BB1CD9E1Q37453323-0BFBEAB5-2EB2-4479-B308-730967E5F426Q37609442-4CC9885C-E838-44B1-B094-8834389BFC49Q37634947-D6EFF237-C53B-493E-8574-6BC361C32A72Q37697557-4C941897-76BA-4C5D-9A4B-D6CB81D1E674Q38201682-4CF8FD17-C1EE-4274-AF77-82BB6631FE82Q38392332-9589CB05-A125-4F32-A24D-74715C01D414Q38868660-FACA53ED-505F-4AAA-AB37-A32BD12FB8FDQ38909036-72475436-3145-4781-A155-4810C6DCE70FQ39370122-F5338D0D-BB98-401E-90D0-C16B76243917Q40039318-580EF38A-9FA5-4DB4-892D-1E29955156DFQ40207742-CA4A4FFD-F473-4586-A1B4-5C062F2E7049Q41552970-00EF54D2-8F67-4159-ACEB-13FC96DB9C7AQ42366479-92F4184A-EE3F-42D5-BA9E-3ADD00C0C174Q44075043-288A2B31-CE6A-4847-944D-3E2D580EE980Q44788875-C880A709-82FE-4E6E-979A-93A9772610A7Q45023889-D6CAA455-9E38-4ACC-B2A3-2FA174F46186Q45054590-2E7D3096-19FD-4ECB-B66F-64902EFD4D86Q46107165-FEBEDBCB-CBA1-4FD8-9EA6-6CEE691F9C22Q46633082-845D3687-3E14-43A8-BC62-C9E01A885C42Q46880177-A5901FF8-714A-4320-9AF0-30B45050D0B9Q47098687-218C0B7D-F11A-44AF-8953-006C4CD3A404
P2860
Cohort study based on the seventh edition of the TNM classification for gastric cancer: proposal of a new staging system.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Cohort study based on the seve ...... posal of a new staging system.
@en
Cohort study based on the seve ...... posal of a new staging system.
@nl
type
label
Cohort study based on the seve ...... posal of a new staging system.
@en
Cohort study based on the seve ...... posal of a new staging system.
@nl
prefLabel
Cohort study based on the seve ...... posal of a new staging system.
@en
Cohort study based on the seve ...... posal of a new staging system.
@nl
P2093
P356
P1476
Cohort study based on the seve ...... posal of a new staging system.
@en
P2093
Hans-Michael Behrens
Harald Held
Jörg T Hartmann
Nicolas T Schwarz
Thomas Becker
Viktoria S Warneke
P304
P356
10.1200/JCO.2010.34.4358
P407
P577
2011-05-02T00:00:00Z